SITE007-0236

SITE007 (JPN) › SITE007-0236

SITE007-0236

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-06-12

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 62); relationship: not assessed

moderate assessed

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-30 (study day 14); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.